about
Role of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcusExogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination PostinfluenzaSpleen-resident CD4+ and CD4- CD8α- dendritic cell subsets differ in their ability to prime invariant natural killer T lymphocytes.Glycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophages.A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection.Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damagesA Toll-Like Receptor 5 Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and Influenza Virus-Associated Pneumococcal Mouse Infections.Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma.NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumorsFHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection.Role of type 1 natural killer T cells in pulmonary immunity.Mechanisms of Invariant NKT Cell Activity in Restraining Bacillus anthracis Systemic Dissemination.[iNKT cells: potential therapeutic targets to fight anthrax].Neutrophilic NLRP3 inflammasome-dependent IL-1β secretion regulates the γδT17 cell response in respiratory bacterial infections."Universal Flu Vaccine": Can NK Cell-mediated ADCC Tip the Scales?Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection.CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells.Key role for respiratory CD103(+) dendritic cells, IFN-γ, and IL-17 in protection against Streptococcus pneumoniae infection in response to α-galactosylceramide.Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases.Type I NKT-cell-mediated TNF-α is a positive regulator of NLRP3 inflammasome priming.Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides.Critical Role for Very-Long Chain Sphingolipids in Invariant Natural Killer T Cell Development and Homeostasis.Role of marginal zone B lymphocytes in invariant NKT cell activation.Type I IFN Receptor Signaling Controls IL7-Dependent Accumulation and Activity of Protumoral IL17A-Producing γδT Cells in Breast Cancer.A Y chromosome-linked factor impairs NK T development.Thymic Program Directing the Functional Development of γδT17 Cells.Role of T Cells in -Galactosylceramide-Mediated ImmunityNKT cell immune responses to viral infectionActivation of Invariant NKT Cells by Toll-like Receptor 9-Stimulated Dendritic Cells Requires Type I Interferon and Charged GlycosphingolipidsTLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells
P50
Q27026700-D3C1DE17-43F1-43B0-98CA-4D7C0B4DCBF0Q30394781-2596C8E1-0649-4F22-9727-B4B9B8074DBDQ34069630-808651B9-E374-470C-A7BE-25FCFBD72B8BQ34257399-3287A1CC-D069-48B0-9C1F-2C209EC08C60Q35235639-DFC850E6-42C0-4CA5-81EF-4366E7BFF30FQ35783980-1F96F86D-A144-43A9-8A28-6B3667A5CE68Q35841871-85689AE8-BFFF-4A41-A3D8-2E91E1A40E52Q36075829-953F0AC9-2A48-458D-9F8E-04F272546630Q36229379-34EE2B6F-DB41-466B-A947-176302FFA62DQ36456479-B0DA6DAA-AEF3-4DBC-89FF-EDBA78AAA51BQ36568780-164850BD-3117-448B-A21F-A8C10A4A343AQ36911822-8D1B1D3A-6BFB-4EEF-8089-A819755378C6Q37157425-187BD401-22AC-4150-91FF-B4AAE543B402Q37637908-34326262-A69B-4B1A-BEF5-48CCB593BB08Q38150638-780090BE-9193-4ABF-81B2-BC964DDDFF08Q39412754-E31B3800-43A1-4F5B-86F2-9CB67600D49AQ40173247-00696DA3-B28C-4B9A-A287-B08CB2658FD6Q40386169-864E2240-5FBD-477D-985A-5C872BEC2FA3Q40609504-DFF95CD3-032D-419D-AFE0-E76CFA17143DQ40661474-FECD9CD2-157E-40CC-83AC-72C69527226CQ41668932-2CC6990F-DE51-438E-A00E-D57FDF7F4C35Q42717336-D9127CF0-3F64-4C81-A973-E1A6DD5DFAD5Q44467140-21000697-2A74-4770-8FF5-2ECE96452FECQ44483781-D5DD4A67-679B-48D5-842E-2A6E666008C1Q44492801-75EFD936-5225-436F-B8B4-AD3DE4BFB670Q45367393-53E39B43-789A-41B7-A772-7A8FD56136EDQ46155303-C1323EFC-1FA2-47C2-A050-F0109FF10C1EQ47132347-AD31121F-8A4E-4508-9209-DDBF33B68D9AQ47884480-46200DA9-D5D2-4E44-9839-C03F2CC01B2FQ50085239-88FD870F-FF70-412B-A8D4-C90CFE42FB24Q51739331-0B78026B-7210-405E-9914-97CBFC7E71C9Q55365838-8469F262-C96C-4106-985D-963EDF7C72C4Q57831249-D50124F9-DCC4-431E-A002-17E1C31083EEQ57831257-252D18DC-7E76-4C48-9C32-0BB5F74D0D7DQ57831266-24C7A49E-F27F-48D4-8376-0545E9799BC0Q64083775-438F0DA2-9E69-4237-B282-0C743045746D
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Christophe Paget
@ast
Christophe Paget
@en
Christophe Paget
@es
Christophe Paget
@nl
Christophe Paget
@sl
type
label
Christophe Paget
@ast
Christophe Paget
@en
Christophe Paget
@es
Christophe Paget
@nl
Christophe Paget
@sl
prefLabel
Christophe Paget
@ast
Christophe Paget
@en
Christophe Paget
@es
Christophe Paget
@nl
Christophe Paget
@sl
P1053
P-5165-2014
P106
P1153
22938939500
P21
P214
14149106272068492432
P2798
P31
P3829
P496
0000-0002-5374-5407